MARC details
| 000 -LEADER |
|---|
| fixed length control field |
01202nam a22002897a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
IIITD |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20240118153135.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
240115b xxu||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780008503994 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
IIITD |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
920 |
| Item number |
BOU-M |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Bourla, Albert |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
Moonshot : |
| Remainder of title |
inside Pfizer's nine-month race to make the impossible possible |
| Statement of responsibility, etc |
by Albert Bourla |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Name of publisher, distributor, etc |
HarperCollins, |
| Place of publication, distribution, etc |
London : |
| Date of publication, distribution, etc |
©2022 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
216 p. : |
| Dimensions |
24 cm. |
| 501 ## - WITH NOTE |
|---|
| With note |
Include Bibliography |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Title |
Preface: Luck never comes to the unprepared |
| -- |
Business NOT as usual |
| -- |
What is obvious is not always right |
| -- |
Thinking big makes the impossible possible |
| -- |
Lightspeed |
| -- |
The ultimate joy |
| -- |
Past, present, future |
| -- |
Manufacturing, the second miracle |
| -- |
Equity : easier said than done |
| -- |
Navigating a political minefield |
| -- |
A beacon of hope |
| -- |
The science of trust |
| -- |
A pro-patient, pro-innovation agenda |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pfizer Inc |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Viral vaccines |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
COVID-19 (Disease)--Prevention |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drug development |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Vaccines industry |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
COVID-19 (Disease)--Vaccination |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Biotechnology |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Immunology |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Books |
